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Metabolic disorders due to methanol poisoning
Tomas Saleka, Petr Humpolicekb,c, Petr Ponizilb,d
Aim. The aim of this study is to compare markers of glomerular filtration rate (GFR), estimated GFR (eGFR), and meta-
bolic parameters between admission and recovery in 13 patients of Tomas Bata hospital with methanol poisoning 
during methanol problems in the Czech Republic in 2012. The impact of methanol concentration and age on metabolic 
parameters were discovered at the time of admission to hospital. 
Materials and Methods. The serum osmolality, methanol, ethanol, creatinine, cystatin C, Troponin I, ALT, plasma pH 
and lactate were measured in these 13 patients. The eGFR from serum creatinine (creatnine eGFR) and from cystatin 
C (cystatin C eGFR) were also determined. 
Results. Increased serum osmolality and markers of metabolic acidosis are key indirect laboratory findings in patients 
with methanol poisoning. There were no significant changes in eGFR in our patients between admission and recovery. 
Increased serum troponin I concentration was confirmed as an indicator of myocardial necrosis in four patients. Two 
patients developed acute kidney injury (AKI) before admission.  
Conclusions. We found statistically significant differences in serum osmolality concentration, plasma pH and lactate 
between admission and recovery. We found no changes in eGFR between admission and recovery. One patient had 
vision problems due to damage to the occipital lobes. Methanol poisoning may cause increase in markers of cardiac 
damage.
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INTRODUCTION
Methanol poisoning is a serious medical, social and 
economical problem. Mass methanol poisonings are rare 
but occur both in developed and developing countries1. 
Accidental cases of methanol poisoning are reported2. 
Suicide attempts using pure methanol are also presented 
in the literature3. Almost all cases of acute methanol toxic-
ity result from accidental ingestion4. Methanol has rela-
tively low toxicity and its metabolism is responsible for 
the transformation of methanol to its toxic metabolites, 
especially formic acid5. An interesting fact is that toxic 
and lethal doses of methanol have not hitherto been deter-
mined unequivocally. 15 mL of 40% methanol have caused 
death in some individuals, whereas others have survived 
consuming as much as 500 mL of such solution. These 
differences are probably caused by the simultaneous etha-
nol consumption, different folate content in the diet or 
the activity of methanol metabolism systems6. However, 
the minimal lethal dose of methanol in humans has been 
assumed to be 1 g per kg body weight (b.w.) in persons 
not having simultaneously consumed ethanol7. 
Typical features of methanol intoxications include 
metabolic acidosis, hyperosmolality, increased osmolar 
gap, retinal damage with blindness, damage to putamen 
and caudate with neurologic dysfunction. Metabolic aci-
dosis is caused by formic acid, lactic acid, and ketones. 
Methanol is oxidized by alcohol dehydrogenase to form-
aldehyde, which is then metabolized by formaldehyde 
dehydrogenase to formic acid. Formate acid is an inhibi-
tor of mitochondrial cytochrome c oxidase which causes 
histotoxic hypoxia8. This leads to reduced adenosine 
triphosphate (ATP) production. Neurotoxic effects of 
formic acid to neurons and glial cells was also demon-
strated in neural cultures9. The optic nerve is especially 
sensitive to reduced ATP production. This is due to its 
neurons’ having long axons and very small diameter10. 
Brain changes can be demonstrated by computed tomog-
raphy and magnetic resonance imaging11. Formate is also 
toxic to retinal cells12. There is a high level of free radical 
production during acute formic acid poisoning in animal 
models13. Formate is mainly responsible for metabolic 
acidosis14. Differential diagnosis of alcohol drinkers with 
high levels of serum osmolality, increased osmolar gap 
and metabolic acidosis also include isopropyl alcohol in-
toxication15. Definitive diagnosis of methanol ingestion 
requires determination of methanol by gold standard test 
which is gas chromatography16. Acid base balance is fre-
quently discussed in patients with methanol intoxication. 
Markers of GFR and cardiac damage are not discussed in 
the literature in such clinical situations. For this reason we 
evaluated these markers in this clinical setting. 
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MATERIAL AND METHODS
The study included 13 patients with methanol poi-
soning at the Tomas Bata hospital in Zlin. There were 
7 males and 6 females. The age of patients ranged from 
28 to 79 years, mean 53 years. All patients survived. Two 
patients with the lowest methanol concentration were 
treated only with ethanol. Ten patients were treated with 
both hemodialysis and ethanol. One patient of this com-
bination treatment group also had fomepizol. The onset 
of dialysis treatment ranged from 15 min to 6 h after 
admission. Serum osmolality was measured by freezing 
point depression. Serum methanol was measured by gas 
chromatography. Other serum markers were measured by 
automated Abbott Architect analyzer. Serum ethanol was 
determined by enzymatic photometry. Serum creatinine 
was measured by a standardized photometric enzymatic 
method traceable to NIST SRM 967 reference materi-
al17. Creatinine eGFR was estimated by the Lund Malmö 
equation18. Cystatin C was determined by a standardized 
immunoturbidimetric technique traceable to ERM DA 
471/IFCC reference material19. Cysstatin C eGFR was 
calculated by equation validated for this method and 
analyser. Serum troponin I concentration was performed 
using immunochemiluminiscent technique. Serum alanin 
aminotransferase was determined by enzymatic method 
with pyridoxal phosphate activation. Plasma pH was de-
termined by an electrochemical method on a Radiometer 
acid-base analyzer. We compared both creatinine eGFR 
and cystatin C eGFR in 13 methanol poisonings at admis-
sion and after recovery. We also compared osmolality, 
pH, ALT and lactate between admission and recovery. 
We looked at serum troponin I concentration which is a 
marker of cardiomyocyte necrosis. We used Risk, Injury, 
Failure, Loss, End-Stage Renal Disease (RIFLE) criteria 
for the diagnosis of acute kidney injury20. Urine output 
was measured over ml/kg/hour in twelve patients. The 
clinical and laboratory status of one patient was so good 
that urine volume was not evaluated. The study was car-
ried out according to the latest Declaration of Helsinki. 
It was approved by the Ethic Committee of Tomas Bata 
Hospital. We were allowed to collect and anonymously 
report the retrospective data of patients.
Statistical evaluation
Impact of methanol intoxication on metabolic mark-
ers was studied. These markers were followed: osmolality, 
Lactate and pH. To discover the relationship between the 
level of methanol intoxication and these markers three 
statistical tests were used,  paired t-tests for differences 
between the levels of individual markers at the beginning 
and at the end of hospitalization, correlations between 
individual markers, age of patients and methanol level 
(mmol/L) and linear regression with age and methanol 
level as fixed factors. 
RESULTS 
Key results of each patient are summarized in Table 1.
We found statistically significant differences in serum 
osmolality concentration, plasma pH and lactate between 
admission and recovery. The results of paired two-sample 
Student's t-test are shown in Table 2. A significant shift 
in osmolarity, lactate and pH level was found. The differ-
ences between the level of osmolality, pH and lactate at 
the beginning and at the end of therapy were significant 
at the P≤0.01; P≤0.01 and P≤0.05, respectively.
Table 1. Sex, age, methanol concentration and all studier markers at admission and discharge for each patient.
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(µmol/L)
Osmolality 
(mmol/kg)
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(mmol/L)
pH
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D
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s
adm. dis. adm. dis. adm. dis. adm. dis. adm. dis.
M 69 5 0.95 0.98 68 72 294 288 7.39 7.42 2.27 No
F 58 76 0.77 0.90 71 58 390 281 - - 7.11 7.47 1.72 YES
F 63 55 1.12 0.92 79 56 373 288 0.9 1.4 7.09 7.41 4.67 YES
M 42 12 0.66 0.63 73 75 303 - 1.5 7.30 7.40 1.56 YES
F 35 33 1.27 1.25 77 55 348 290 8.3 7.08 7.42 0.57 YES
M 48 62 1.68 0.62 167 44 374 280 7.6 6.82 7.50 2.76 YES
M 79 10 1.55 0.94 80 61 310 282 4.4 0.9 7.33 7.49 2.3 YES
F 58 38 0.80 0.72 84 58 378 286 5.1 1.8 7.09 7.46 5 YES
M 42 63 0.70 0.70 68 80 409 - 1.4 - 7.41 7.41 1.43 YES
F 62 30 1.01 0.90 76 60 311 291 2.0 1.0 7.18 7.45 4.05 YES
M 58 61 1.63 1.19 124 74 383 287 12.8 1.7 6.76 7.51 1.25 YES
F 52 138 0.92 0.86 44 45 463 284 1.5 1.4 7.22 7.45 4.38 YES
M 28 12 0.79 0.79 73 86 300 283 0.9 1.0 7.33 7.36 - No
Mean 
±SD
53.38 
±14.15
45.76  
±36.50
1.06  
±0.35
0.88  
±0.19
83.38  
±30.50
63.38  
±12.98
356.61  
±51.01
285.45  
±3.70
4.21  
±3.90
1.31  
±0.36
7.16  
±0.20
7.44  
±0.04
2.66  
±1.50
adm. is the marker level at the admission time; 
dis. is the marker level at the recovery time = discharge.
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that the increase in methanol level by 10 mmol/L 
will increase the osmolality about 13.0 ± 1.4 mmol/L. 
We found increased troponin I above 99th percentile of 
healthy population in four patients (male 58 years old, 
females 58, 35 and 58 years old). None of the patients 
had clinical features of acute coronary syndrome and elc-
trocardiography showed no ischemic changes.
There was no difference in either creatinine eGFR or 
cystatin C eGFR between admission and recovery. Two 
patients had AKI according to RIFLE criteria.  They met 
GFR criteria but not urine volume criteria (urine output 
below 0.5 mL/kg/h during hospital stay). AKI developed 
before admission to the hospital. Creatinine and cystatin 
C decreased and GFR increased in these two patients 
during treatment.
One patient - a 48 years old man - had vision prob-
lems. Magnetic resonance imaging of brain revealed ce-
rebral white matter swellings (semioval center). Most of 
the impairments impacted the corona radiata center in 
the subcortical occipital regions. There was also haemor-
rhagicnecrosis of basal ganglia, especially putamen and 
the globus pallidus.
DISCUSSION
We compared metabolic parameters and markers of 
GFR between admission and discharge. We found in-
creased serum osmolarity and metabolic acidosis in the 
majority of patients. It has been repeatedly reported, that 
serum osmolality increases with methanol poisoning21 and 
that methanol intoxication causes high anion gap meta-
bolic acidosis22. The acidosis seen in early clinical course 
is caused directly by formic acid production. Lactate is 
produced later as formic acid interferes with intracellular 
respiration and promotes anaerobic metabolism5. These 
findings are seen in common clinical practice. Differential 
diagnosis of alcohol intoxication includes ethanol, ethyl-
englycol and isopropyl alcohol intoxication15.
Table 2. Average differences in marker levels at the beginning and at the end of therapy.
Cystatin C 
(mg/L)
Creatinine 
(µmol/L)
Osmolality 
(mmol/kg)
Lactate 
(mmol/L)
pH ALT
eGFR  
Cystatin C
eGFR
Creatinine
0.18 ±  0.09 20.00 ±9.88 71.27 ±15.56** 3.24 ±1.20* -0.28 ±0.06** 0.77 ±0.71 -0.26 ±0.14 -0.23 ± 0.13
(Average change ± standard error of the mean). The statistical differences by paired t-test (t value).
ALT is alanine aminotransferase; eGFR is estimated glomerular filtration rate. 
* P≤0.05, ** P≤0.01.
Table 3. Correlation between the individual markers and age 
or methanol level.
Osmolality  
(mmol/kg)
Lactate  
(mmol/L)
pH
rage -0.43 -0.35 0.06
rmet 0.95** 0.01 -0.27
rage is the Pearson correlation coefficient between age and marker rmet is 
the Pearson correlation coefficient between methanol level and marker. 
** P≤0.01 by testing for the significance of the correlation coefficient.
Table 4. Multiple correlation between the individual markers 
and combination of age with methanol.
Osmolality  
(mmol/kg)
Lactate 
(mmol/L)
pH
rmet/age 0.97** 0.36 0.27
rmet/age is the multiple correlation coefficient between age ant metha-
nol level as independent variables and marker as dependent variable. 
**P≤0.01 by testing for the significance of the muptiple correlation 
coefficient.
Table 5. Partial correlation between the individual markers and age or methanol with removed 
effect of second variable.
Osmolality Lactate pH
Rparcage -0.622 -0.361 -0.010
Rparcmet 0.964* -0.083 -0.267
Rparcage is partial correlation between marker and age (effect of methanol level is removed). 
Rparcmet is partial correlation between marker and methanol level (effect of age is removed). 
* P≤0.05 by testing for the significance of the partial correlation coefficient.
The significant effect on the osmolality was subse-
quently confirmed by the correlation between osmolality 
and methanol level (Table 3, P≤0.01).
The correlation between osmolality and methanol 
level was confirmed by the multiple correlation (Table 
4). The correlation coefficient between osmolality and 
age methanol was 0.97 which, compared to the correla-
tion to methanol only (Table 2; 0.95), showed a nonsig-
nificant increase. The small impact of age was confirmed 
by partial correlation coefficient (Table 5) which con-
firmed the relations between the osmolality and metha-
nol (P≤0.01; r=0.96) but not between age and methanol. 
Moreover, based on the linear regression we can state 
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We found no statistically significant changes in eGFR. 
The small number of patients may also contribute to this 
result. Further, we are not able to accurately determine 
small GFR changes in patients on dialysis treatment. Two 
patients fullfilled the GFR criteria for AKI. We are unable 
to conclude that methanol intoxication caused this state. 
Dehydration could also have played a part in the develop-
ment of AKI. Nephrotoxic drugs, sepsis and multiorgan 
dysfunction probably did not cause AKI in our patients. 
Acute renal failure developed in some studies in patients 
with methanol poisoning23. The limitation of our study 
is that we did not measure methanol and formic acid in 
urine. This could be useful to better understand the kinet-
ics of methanol and formate elimination24.
Formate is especially toxic for nerve cells and the op-
tic nerve. These cells need large amounts of energy. The 
inhibition of cytochrome c oxidase leads to low levels 
of ATP and cell dysfunction. The great sensitivity of the 
optic nerve to formate is well clinically documented in 
large epidemic problems in Cuba and in animal models10. 
Our patients were assessed by an ophthalmologist. One 
patient had vision problems. Magnetic resonance imag-
ing of the brain revealed cerebral white matter swellings 
(semioval center). Most of the impairments impacted the 
corona radiata center in the subcortical occipital regions. 
There was also the hemoragic necrosis of the basal gan-
glia, especially the putamen and globus pallidus. Similar 
findings have been described in the literature11. Today, 
cardiac troponins are the gold standard for the diagnosis 
of myocardial necrosis25. We found no cardiac troponins 
in patients with methanol poisoning in the database of 
PubMed. Four of our patients had elevated serum levels 
of troponin I.
In summary, our results confirm well-known data on 
acid base and osmolarity disorders in patients with metha-
nol poisoning. One new finding was elevation of troponin 
I in some patients. The major limitation of our study is 
the small number of patients and the fact that we do not 
measure serum or urine formic acid.
CONCLUSIONS
We found statistically significant differences in serum 
osmolality concentration, plasma pH and lactate between 
admission and recovery. We found no changes in eGFR 
between admission and recovery. We found increased 
serum troponin I concentration as an indicator of myo-
cardial necrosis in four patients. One patient had vision 
problems due to damage to occipital lobes. This should 
be taken into account in treating these patients.
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LETTER TO THE EDITOR:  
METABOLIC DISORDERS DUE TO METHANOL 
INTOXICATION
Hossein Sanaei-Zadeh
Correspondence: Dr Hossein Sanaei-Zadeh, Medical School, Shiraz University of 
Medical Sciences, Emergency Room/Division of Medical Toxicology, Hazrat Ali-Asghar 
(p) Hospital, Meshkinfam Street, 7143918796 Shiraz, Iran, e-mail: h-sanaiezadeh@
tums.ac.ir
Dear Editor,
I read with interest the study performed by Salek et al. 
recently published on-line in your journal1. Interestingly, 
the authors have been trying to evaluate changes in some 
metabolic parameters in methanol-poisoned patients that 
have been completely obvious from the very first begin-
ning. In other words, they compared serum osmolality 
concentrations, plasma pH, and lactate between admis-
sion and recovery of 13 methanol-poisoned patients and 
found statistically significant differences in this compari-
son. However, the reason for this comparison was not 
discussed in the article. It is well known that methanol is 
initially metabolized to formaldehyde and then to formic 
acid2. Formic acid causes a metabolic acidosis and di-
rectly inhibits mitochondrial cytochrome oxidase leading 
to cellular hypoxia and increase in the lactate concentra-
tions, further exacerbating the acidosis3. Apart from this, I 
had some concerns regarding the management of their pa-
tients and the influences of the treatment on the studied 
parameters, as well. Except description about one patient 
who had presented with vision problem, the authors did 
not mention anything about their patients’ symptoms and 
signs, hydration of their patients, and administration of 
sodium bicarbonate to them. They managed two patients 
only with ethanol because they had the lowest methanol 
concentration in their series. It should be pointed out that 
the management priorities in methanol poisoning depend 
upon the circumstance of presentation and not methanol 
concentration, per se. For instance, if the patients have 
any of the pH<7.25-7.30, visual sign and symptoms, renal 
failure, significant electrolyte disturbances unresponsive 
to conventional therapy, serum methanol concentration 
above 50 mg/dL, or deterioration in vital signs despite 
intensive supportive care, hemodialysis should be per-
formed2. Furthermore, it is not clear why one of the 
patients was concomitantly treated with ethanol, fomepi-
zole, and hemodialysis. Of note, fomepizole is recom-
mended as a first-line treatment for methanol-poisoned 
patients who present without ophthalmologic impairment 
or severe acidosis2,4. In this case, fomepizole may obviate 
the need for hemodialysis2,4. Also, both fomepizole and 
ethanol alter the metabolism of each other. Therefore, 
co-administration of ethanol and fomepizole has not been 
recommended2. 
The authors showed that there were no significant 
changes in estimated glomerular filtration rate (eGFR) 
between admission and recovery in their patients. Did 
they pay attention to the influence of hydration of the 
patients (if any) at hospital admission on their eGFR that 
might happen before taking blood samples? If so, was 
their sample size (only 13 patients) statistically sufficient 
for reaching such a conclusion? 
I wonder if they considered the effects of hemodialysis 
and the administration of ethanol and sodium bicarbonate 
on pH, serum osmolality, or correlation between osmo-
lality and methanol level. In Table 1, I noted that there 
were missing data about osmolality concentrations and 
lactate levels at the recovery time for two and six patients, 
respectively. Could these missing data interfere with the 
accurate statistical analysis and calculation of the partial 
correlation coefficient between osmolality and methanol 
level, and lactate and methanol level?
Moreover, it is not clear what logic relationship exists 
between methanol poisoning and serum alanine amino-
transferase for which the authors have compared this pa-
rameter between admission and recovery of the patients. 
In addition, four patients had increased troponin I 
above 99th percentile of healthy population. It should be 
mentioned that these patients had no clinical features of 
acute coronary syndrome and their electrocardiographs 
were normal. Does it really show cardiac damage in these 
patients? 
Finally, the authors had two patients with acute kidney 
injury (AKI) that was developed before admission to the 
hospital and they could not find any explanation for that 
except dehydration. Could myoglobinuria have a role in 
the development of AKI in their patients2? 
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Dear Professor Sanaei-Zadeh,
Thank you for your letter of comment on the article 
“Metabolic disorders due to methanol intoxication”. It 
is difficult to follow the logic of the first part of your 
comments. Changes obvious from the outset, has no 
meaning. The authors mentioned high levels of serum 
osmolarity and metabolic acidosis on page 1 along with 
reasons for measuring GFR and markers of cardiac dam-
age. Naturally, treatment resulted in improved acid base 
dysbalance. The authors have also provided additional de-
tails to answer your questions as follows: all patients were 
examined physically. This included hydration/dehydration 
assessment and all patients with a pH under 7.1 received 
Sodium Bicarbonate. Two only had clinical signs of de-
hydration but no AKI according to RIFLE criteria. Four 
patients were unconscious. This presented problems for 
us. Some of these had vomiting while the others were ad-
mitted on suspicion of alcohol intoxication. All had oph-
thalmological and neurological examination.Treatment 
with ethanol was followed by fomepizol in one patient. 
Treatment was closely monitorted and end of therapy was 
determined according to serum methanol concentration. 
Missing data in Table 1: There were a large number of 
blood samples between the first and last sampling for 
each patient. Some patients had physiological results a 
few hours after treatment. For this reason, the physician 
did not order all the tests at the end of the hospital stay. 
Relation between methanol poisoning and ALT. Nearly all 
drugs and toxins can increase liver test results like ALT. 
Troponin. Cardiac troponin I and T are cardio specific. 
They are not released from any other organ. There were 
2 patients with acute kidney injury. These had no clinical 
signs of dehydration. Myoglobinuria as a cause of AKI. 
The first patient with AKI had an alanineaminotransfer-
ase (AST) level of 0:51 ukat/L and negative urine strip 
test for blood. Clinically significant myoglobinuria was 
unlikely.
You are right, a sample size of 13 is very small for 
statistical conclusions. Unfortunately, methanol poison-
ing cannot be created to satisfy medical publications. We 
hope that some of your questions have been answered. 
